Merck & Co. (MRK)
(Delayed Data from NYSE)
$127.51 USD
-0.75 (-0.58%)
Updated May 3, 2024 03:59 PM ET
After-Market: $127.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Brokerage Reports
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 261 - 280 ( 392 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Three Notable Areas of Development in Companion Animal Health; Our Takeaways from VMX 2018
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
A New Wave of Biotechs Reshaping the Animal Health Market; Initiate Coverage on Aratana and Kindred Bio With Buy Ratings
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
A Wind of Change Is Blowing Through the Animal Health Market
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S